Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China.
Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, China.
CNS Neurosci Ther. 2023 Jan;29(1):228-238. doi: 10.1111/cns.13998. Epub 2022 Oct 26.
This study aimed to evaluate the effects of the depletion of SAM and SH3 domain-containing protein 1 (SASH1) on functional recovery after spinal cord injury (SCI) and to investigate the possible mechanism of SASH1 knockdown in astrocytes facilitating axonal growth.
SCI model was established in adult rats. SASH1 small interfering RNA (siSASH1) was used to investigate its function. Hindlimb motor function was evaluated by the Basso-Bresnahan-Beattie (BBB) assay. The gene expressions were evaluated by the methods of qRT-PCR, Western-blotting, ELISA, and immunohistochemistry.
SASH1 knockdown improved the BBB scores after SCI and significantly reduced GFAP expression. In cultured spinal astrocytes, siSASH1 treatment decreased interferon-γ release and increased brain-derived neurotrophic factor (BDNF) release. When cocultured with SASH1-knockdown astrocytes, axonal growth increased. The neuronal tropomyosin receptor kinase B (BDNF receptor) expression increased, especially in the axonal tips. SASH1 expression increased while NSCs differentiated into glial cells, instead of neurons. After SASH1 depletion, differentiated NSCs maintained a higher level of Nestin protein and an increase in BDNF release.
These results indicate that SASH1 acts as an astrocytic differentiation-maintaining protein, and SASH1 downregulation limits glial activation and contributes toward functional recovery after SCI.
本研究旨在评估 SAM 和 SH3 结构域蛋白 1(SASH1)耗竭对脊髓损伤(SCI)后功能恢复的影响,并探讨 SASH1 在星形胶质细胞中敲低促进轴突生长的可能机制。
在成年大鼠中建立 SCI 模型。使用 SASH1 小干扰 RNA(siSASH1)来研究其功能。通过 Basso-Bresnahan-Beattie(BBB)评分评估后肢运动功能。通过 qRT-PCR、Western-blotting、ELISA 和免疫组织化学评估基因表达。
SASH1 敲低可改善 SCI 后的 BBB 评分,并显著降低 GFAP 表达。在培养的脊髓星形胶质细胞中,siSASH1 处理可减少干扰素-γ释放并增加脑源性神经营养因子(BDNF)释放。当与 SASH1 敲低星形胶质细胞共培养时,轴突生长增加。神经元原肌球蛋白受体激酶 B(BDNF 受体)表达增加,尤其是在轴突尖端。SASH1 表达增加,而 NSCs 分化为胶质细胞,而不是神经元。SASH1 耗竭后,分化的 NSCs 保持更高水平的巢蛋白和 BDNF 释放。
这些结果表明,SASH1 作为一种星形胶质细胞分化维持蛋白发挥作用,SASH1 下调限制了胶质细胞的激活,并有助于 SCI 后的功能恢复。